Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2007 Publisher: Pharma Global Limited Hudson Road Sandycove Co Dublin Ireland
Known hypersensitivity to benzalkonium chloride, sodium cromoglycate or other constituents.
The solution should be discarded 1 month after first opening the bottle or if any turbidity develops. Do not use if the bottle has been opened prior to receipt. Vividrin Eye Drops and Vividrin Hay Fever Eye Drops contain benzalkonium chloride. Do not wear soft contact lenses during the period of use.
None known.
Use in Pregnancy: Vividrin Eye Drops and Vividrin Hay Fever Eye Drops should be used cautiously during pregnancy and lactation. The widespread use of sodium cromoglycate has yet to reveal any adverse effects to mother or child during pregnancy.
*
Use in Lactation:* It is not known whether sodium cromoglycate is excreted in human breast milk but on the basis of its physicochemical properties, this is considered unlikely. There is no information to suggest that the use of sodium cromoglycate has any undesirable effects on the baby.
Transient stinging or blurred vision may occur on instillation. Do not drive or operate machinery until proper vision is restored.
Transient stinging and burning may occur after instillation, other symptoms of local irritation have been reported rarely.
Sodium cromoglycate forms insoluble complexes with metal ions resulting in solution turbidity.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
